Titre : Transmission synaptique

Transmission synaptique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement System Proteins
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Transmission synaptique : Questions médicales les plus fréquentes", "headline": "Transmission synaptique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Transmission synaptique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-29", "dateModified": "2025-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Transmission synaptique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes physiologiques du système nerveux", "url": "https://questionsmedicales.fr/mesh/D009424", "about": { "@type": "MedicalCondition", "name": "Phénomènes physiologiques du système nerveux", "code": { "@type": "MedicalCode", "code": "D009424", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Potentiels synaptiques", "alternateName": "Synaptic Potentials", "url": "https://questionsmedicales.fr/mesh/D055366", "about": { "@type": "MedicalCondition", "name": "Potentiels synaptiques", "code": { "@type": "MedicalCode", "code": "D055366", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561.830.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Potentiels post-synaptiques excitateurs", "alternateName": "Excitatory Postsynaptic Potentials", "url": "https://questionsmedicales.fr/mesh/D019706", "about": { "@type": "MedicalCondition", "name": "Potentiels post-synaptiques excitateurs", "code": { "@type": "MedicalCode", "code": "D019706", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561.830.750.199" } } }, { "@type": "MedicalWebPage", "name": "Potentiels post-synaptiques inhibiteurs", "alternateName": "Inhibitory Postsynaptic Potentials", "url": "https://questionsmedicales.fr/mesh/D053444", "about": { "@type": "MedicalCondition", "name": "Potentiels post-synaptiques inhibiteurs", "code": { "@type": "MedicalCode", "code": "D053444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561.830.750.400" } } }, { "@type": "MedicalWebPage", "name": "Potentiels post-synaptiques miniatures", "alternateName": "Miniature Postsynaptic Potentials", "url": "https://questionsmedicales.fr/mesh/D055369", "about": { "@type": "MedicalCondition", "name": "Potentiels post-synaptiques miniatures", "code": { "@type": "MedicalCode", "code": "D055369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561.830.750.560" } } }, { "@type": "MedicalWebPage", "name": "Sommation des potentiels post-synaptiques", "alternateName": "Postsynaptic Potential Summation", "url": "https://questionsmedicales.fr/mesh/D059227", "about": { "@type": "MedicalCondition", "name": "Sommation des potentiels post-synaptiques", "code": { "@type": "MedicalCode", "code": "D059227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G11.561.830.750.780" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Transmission synaptique", "alternateName": "Synaptic Transmission", "code": { "@type": "MedicalCode", "code": "D009435", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Dietmar Schmitz", "url": "https://questionsmedicales.fr/author/Dietmar%20Schmitz", "affiliation": { "@type": "Organization", "name": "Neuroscience Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. dietmar.schmitz@charite.de." } }, { "@type": "Person", "name": "Christian Lüscher", "url": "https://questionsmedicales.fr/author/Christian%20L%C3%BCscher", "affiliation": { "@type": "Organization", "name": "Department of Basic Neurosciences, Medical Faculty, University of Geneva, CH-1211 Geneva, Switzerland. christian.luscher@unige.ch." } }, { "@type": "Person", "name": "James E Rothman", "url": "https://questionsmedicales.fr/author/James%20E%20Rothman", "affiliation": { "@type": "Organization", "name": "Nanobiology Institute and Department of Cell Biology, Yale University, New Haven, CT, USA." } }, { "@type": "Person", "name": "Kirill Grushin", "url": "https://questionsmedicales.fr/author/Kirill%20Grushin", "affiliation": { "@type": "Organization", "name": "Nanobiology Institute and Department of Cell Biology, Yale University, New Haven, CT, USA." } }, { "@type": "Person", "name": "Manindra Bera", "url": "https://questionsmedicales.fr/author/Manindra%20Bera", "affiliation": { "@type": "Organization", "name": "Nanobiology Institute and Department of Cell Biology, Yale University, New Haven, CT, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.", "datePublished": "2023-04-11", "url": "https://questionsmedicales.fr/article/37065697", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.15125" } }, { "@type": "ScholarlyArticle", "name": "Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis.", "datePublished": "2024-07-12", "url": "https://questionsmedicales.fr/article/39072319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2024.1420292" } }, { "@type": "ScholarlyArticle", "name": "The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis.", "datePublished": "2024-07-08", "url": "https://questionsmedicales.fr/article/38978073", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13075-024-03360-3" } }, { "@type": "ScholarlyArticle", "name": "The Contribution of Complement Protein C1q in COVID-19 and HIV Infection Comorbid with Preeclampsia: A Review.", "datePublished": "2022-06-03", "url": "https://questionsmedicales.fr/article/35661665", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000524976" } }, { "@type": "ScholarlyArticle", "name": "Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.", "datePublished": "2023-06-07", "url": "https://questionsmedicales.fr/article/37286573", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-023-38383-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques de l'appareil locomoteur et du système nerveux", "item": "https://questionsmedicales.fr/mesh/D055687" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes physiologiques du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009424" }, { "@type": "ListItem", "position": 4, "name": "Transmission synaptique", "item": "https://questionsmedicales.fr/mesh/D009435" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Transmission synaptique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Transmission synaptique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Transmission synaptique", "description": "Comment diagnostiquer un dysfonctionnement synaptique ?\nQuels examens sont utilisés pour évaluer la transmission synaptique ?\nQuels symptômes indiquent un problème de transmission synaptique ?\nPeut-on mesurer la transmission synaptique directement ?\nQuels marqueurs biologiques sont associés à la transmission synaptique ?", "url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+System+Proteins&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Transmission synaptique", "description": "Quels symptômes sont liés à une transmission synaptique altérée ?\nComment la dépression affecte-t-elle la transmission synaptique ?\nLes troubles de l'humeur sont-ils liés à la transmission synaptique ?\nQuels signes neurologiques peuvent indiquer un problème synaptique ?\nLa fatigue chronique est-elle liée à la transmission synaptique ?", "url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+System+Proteins&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Transmission synaptique", "description": "Comment prévenir les troubles de la transmission synaptique ?\nLe stress affecte-t-il la transmission synaptique ?\nL'exercice physique influence-t-il la transmission synaptique ?\nLes habitudes de sommeil affectent-elles la transmission synaptique ?\nLa méditation peut-elle améliorer la transmission synaptique ?", "url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+System+Proteins&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Transmission synaptique", "description": "Quels traitements existent pour améliorer la transmission synaptique ?\nLa thérapie cognitive peut-elle aider la transmission synaptique ?\nLes suppléments alimentaires influencent-ils la transmission synaptique ?\nComment la stimulation cérébrale affecte-t-elle la transmission synaptique ?\nLes thérapies comportementales aident-elles la transmission synaptique ?", "url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+System+Proteins&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Transmission synaptique", "description": "Quelles complications peuvent résulter d'une transmission synaptique altérée ?\nLes maladies neurodégénératives affectent-elles la transmission synaptique ?\nComment les troubles de l'apprentissage sont-ils liés à la transmission synaptique ?\nLes troubles psychotiques sont-ils liés à la transmission synaptique ?\nLa schizophrénie affecte-t-elle la transmission synaptique ?", "url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+System+Proteins&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Transmission synaptique", "description": "Quels facteurs de risque influencent la transmission synaptique ?\nL'alimentation joue-t-elle un rôle dans la transmission synaptique ?\nLe tabagisme affecte-t-il la transmission synaptique ?\nLes maladies chroniques influencent-elles la transmission synaptique ?\nLe manque d'activité physique est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+System+Proteins&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un dysfonctionnement synaptique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests électrophysiologiques et des imageries cérébrales peuvent être utilisés." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer la transmission synaptique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM fonctionnelle et l'électroencéphalogramme (EEG) sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de transmission synaptique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la mémoire, des convulsions ou des changements de comportement peuvent survenir." } }, { "@type": "Question", "name": "Peut-on mesurer la transmission synaptique directement ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme la microscopie à fluorescence permettent d'observer la transmission." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés à la transmission synaptique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des protéines comme la synaptophysine peuvent servir de marqueurs pour la synapse." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une transmission synaptique altérée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes incluent des troubles cognitifs, des spasmes musculaires et des douleurs." } }, { "@type": "Question", "name": "Comment la dépression affecte-t-elle la transmission synaptique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La dépression peut réduire la plasticité synaptique, affectant la communication neuronale." } }, { "@type": "Question", "name": "Les troubles de l'humeur sont-ils liés à la transmission synaptique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres dans les neurotransmetteurs peuvent provoquer des troubles de l'humeur." } }, { "@type": "Question", "name": "Quels signes neurologiques peuvent indiquer un problème synaptique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent des tremblements, des troubles de la coordination et des réflexes anormaux." } }, { "@type": "Question", "name": "La fatigue chronique est-elle liée à la transmission synaptique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans la transmission synaptique peuvent contribuer à la fatigue chronique." } }, { "@type": "Question", "name": "Comment prévenir les troubles de la transmission synaptique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel." } }, { "@type": "Question", "name": "Le stress affecte-t-il la transmission synaptique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut altérer la transmission synaptique et la plasticité." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il la transmission synaptique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier favorise la santé neuronale et la transmission synaptique." } }, { "@type": "Question", "name": "Les habitudes de sommeil affectent-elles la transmission synaptique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un sommeil de qualité est crucial pour la régénération synaptique et cognitive." } }, { "@type": "Question", "name": "La méditation peut-elle améliorer la transmission synaptique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la méditation peut augmenter la plasticité synaptique et réduire le stress." } }, { "@type": "Question", "name": "Quels traitements existent pour améliorer la transmission synaptique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les antidépresseurs et les nootropiques peuvent être utilisés." } }, { "@type": "Question", "name": "La thérapie cognitive peut-elle aider la transmission synaptique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut améliorer la plasticité synaptique et la fonction cognitive." } }, { "@type": "Question", "name": "Les suppléments alimentaires influencent-ils la transmission synaptique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments comme les oméga-3 peuvent favoriser la santé synaptique." } }, { "@type": "Question", "name": "Comment la stimulation cérébrale affecte-t-elle la transmission synaptique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La stimulation cérébrale peut renforcer les connexions synaptiques et améliorer la fonction." } }, { "@type": "Question", "name": "Les thérapies comportementales aident-elles la transmission synaptique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent améliorer les interactions neuronales et la plasticité synaptique." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'une transmission synaptique altérée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques, des troubles de l'humeur et des crises." } }, { "@type": "Question", "name": "Les maladies neurodégénératives affectent-elles la transmission synaptique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme Alzheimer altèrent gravement la transmission synaptique." } }, { "@type": "Question", "name": "Comment les troubles de l'apprentissage sont-ils liés à la transmission synaptique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la transmission synaptique peuvent entraîner des difficultés d'apprentissage." } }, { "@type": "Question", "name": "Les troubles psychotiques sont-ils liés à la transmission synaptique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres dans les neurotransmetteurs peuvent contribuer aux troubles psychotiques." } }, { "@type": "Question", "name": "La schizophrénie affecte-t-elle la transmission synaptique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la schizophrénie est associée à des dysfonctionnements dans la transmission synaptique." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent la transmission synaptique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, le stress et la génétique peuvent influencer la transmission." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la transmission synaptique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments favorise une transmission synaptique saine." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la transmission synaptique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut altérer la fonction synaptique et augmenter le risque de troubles." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles la transmission synaptique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent affecter la transmission synaptique." } }, { "@type": "Question", "name": "Le manque d'activité physique est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inactivité physique peut nuire à la santé synaptique et cognitive." } } ] } ] }

Sources (10000 au total)

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.

IgA nephropathy (IgAN) is one of the leading causes of end-stage renal disease (ESRD). Urine testing is a non-invasive way to track the biomarkers used for measuring renal injury. This study aimed to ... In the discovery phase, we analysed 22 IgAN patients who were divided into three groups (IgAN 1-3) according to their estimated glomerular filtration rate (eGFR). Eight patients with primary membranou... In the discovery phase, 747 proteins were identified in the urine of IgAN and pMN patients. There were different urine protein profiles in IgAN and pMN patients, and the bioinformatics analysis reveal... There were abundant complement components in the urine of IgAN patients, indicating that the activation of AP and LP is involved in IgAN progression. Urinary complement proteins may be used as biomark...

Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis.

The complement system has been linked to the etiopathogenesis of rheumatoid arthritis (RA). Patients with RA exhibit a dysregulated profile of lipid molecules, which has been attributed to the inflamm... 430 patients with RA were recruited. New-generation techniques were employed to conduct functional assays of the three pathways of the complement system. Serum levels of various complement components ... After multivariable analysis, several noteworthy associations emerged between the complement system and lipid molecules. Notably, complement components most strongly linked to the lipid profile were C... The correlation between the complement system and lipid molecule patterns is pronounced in patients with RA. This relationship is predominantly positive and primarily associated with upstream compleme...

The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis.

Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) events and CV mortality. Subclinical carotid atherosclerosis is independently associated with rates of incident CV... 430 patients with RA were recruited. Functional assays of the three pathways of the complement system, utilizing new-generation techniques, were assessed. Additionally, serum levels of individual comp... After multivariable adjustment, which included traditional CV risk factors and disease-related data, C3a and C5a exhibited significant positive correlations with carotid intima media thickness. Additi... The complement system and subclinical carotid atherosclerosis are linked in patients with RA....

The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target.

The purpose of this review is to discuss the role of the complement system in the pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) as well as the employment of co... AAV has traditionally been considered a pauci-immune disease until recent findings demonstrated the pathogenic role of the complement system. The complement alternative pathway is crucial in AAV, and ... The increased circulating levels of some complement components - as well as the consumption of others - in patients with AAV suggested a systemic activation of the complement system. Low C3 levels cor...

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.

Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed to determine the value of complement proteins, which are key c... We measured the complement proteins C1q and C3b in CSF by ELISAs in 224 presymptomatic and symptomatic GRN, C9orf72 or MAPT mutation carriers and non-carriers participating in the Genetic Frontotempor... CSF C1q and C3b, as well as plasma C2 and C3, were elevated in symptomatic mutation carriers compared to presymptomatic carriers and non-carriers. In genetic subgroup analyses, these differences remai... Elevated levels of CSF C1q and C3b, as well as plasma C2 and C3, demonstrate the presence of complement activation in the symptomatic stage of genetic FTD. Intriguingly, correlations with several dise...